NICOLE PUTERBAUGH: Open Payments
NPI 1407017270 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,395 in 72 payments from 15 companies in 2025. Trend: 2023 $985 · 2024 $1,636 · 2025 $1,395
Food & beverage: $1,395
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $335 |
| AstraZeneca Pharmaceuticals LP | 7 | $244 |
| Novo Nordisk Inc | 18 | $236 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $113 |
| Lilly USA, LLC | 5 | $89 |
| Edwards Lifesciences Corporation | 2 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 5 | $53 |
| PFIZER INC. | 3 | $50 |
| Exact Sciences Corporation | 2 | $47 |
Products named: UBRELVY, FARXIGA, Ozempic, BIJUVA, AIRSUPRA, QULIPTA, MOUNJARO, SAPIEN 3 Ultra RESILIA.
Industry payments across OH — which companies pay providers there.
